Compare SKYT & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKYT | ATRC |
|---|---|---|
| Founded | 1991 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2021 | 2005 |
| Metric | SKYT | ATRC |
|---|---|---|
| Price | $34.62 | $28.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $26.50 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 1.2M | 811.2K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1842.86 | 74.74 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $442,139,000.00 | $201,630,000.00 |
| Revenue This Year | $40.16 | $15.27 |
| Revenue Next Year | $4.52 | $12.21 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 29.18 | 15.40 |
| 52 Week Low | $8.18 | $25.52 |
| 52 Week High | $36.38 | $43.18 |
| Indicator | SKYT | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 58.86 | 49.37 |
| Support Level | $26.99 | $26.94 |
| Resistance Level | $36.07 | $30.75 |
| Average True Range (ATR) | 1.46 | 1.44 |
| MACD | 0.12 | 0.03 |
| Stochastic Oscillator | 72.41 | 61.44 |
SkyWater Technology Inc is a U.S.-based, independent, pure-play semiconductor foundry providing foundational-node manufacturing, advanced technology development, and advanced packaging services through an integrated, multi-site operating model. It operates within the United States, with fabrication and packaging facilities in Minnesota, Texas, and Florida.l. Its segments include: Legacy SkyWater: A pure-play technology foundry that offers advanced semiconductor development and manufacturing services from its fabrication facility in Bloomington, Minnesota and advanced packaging services from its Kissimmee Florida facility; and SkyWater Texas: A high-volume manufacturer that offers manufacturing services from its fabrication facility in Austin, Texas.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.